GLP-1R Agonists and Their Therapeutic Potential in Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases, a Systematic Review of the Literature
<b>Background/Objectives:</b> GLP-1 receptor agonists (GLP-1RAs) have revolutionized weight loss and shown anti-inflammatory actions in several experimental models of colitis. There has been a wealth of recent data suggesting that GLP-1RA treatment may modify disease outcomes in inflamma...
Saved in:
| Main Authors: | Lena Thin, Wei Ling Teh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/5/1128 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anemia in Inflammatory Bowel Disease: A Neglected Issue in Comprehensive Inflammatory Bowel Disease Management
by: Randy Adiwinata, et al.
Published: (2021-10-01) -
Anti‐Inflammatory Peptides as Promising Therapeutics Agent Against Inflammatory Bowel Diseases: A Systematic Review
by: Kiarash Ghazvini, et al.
Published: (2025-07-01) -
Inflammatory Bowel Diseases: the Surgical Perspective
by: SOCEA Bogdan, et al.
Published: (2019-03-01) -
Crime detective: towards the first description of inflammatory bowel diseases
by: V. V. Balutsky, et al.
Published: (2024-08-01) -
Can inflammatory bowel disease be treated with diet?
by: J P Wright
Published: (2025-04-01)